Queen Mary marks another year of ground-breaking cancer research
On World Cancer Day, Tuesday 4 February, we are celebrating some of the cutting-edge cancer research and developments over the last 12 months from Queen Mary University of London.
Queen Mary's best and brightest have used their research to drive improvements in cancer screening and testing, taking strides towards the development of new treatments like a novel vaccine for pancreatic cancer.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalised vaccine system that could ultimately delay the onset of pancreatic cancer.
IBIS-II study finds anastrozole reduces breast cancer rates long term for high risk postmenopausal women
The Queen Mary University of London professor leading an international breast cancer study says anastrozole – rather than tamoxifen – should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.
In a paper published today in the Journal of Medical Screening, researchers from Queen Mary University of London and King’s College London have found that despite free cancer screening programmes, only 35 per cent take part in all offered programmes.
Our researchers have been working to develop new, non-invasive tests that can make it simpler and easier to detect early-stage cancers.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, according to research by Queen Mary University of London.
Queen Mary University of London researchers have developed a non-invasive test to detect cervical pre-cancer by analysing urine and vaginal samples women collect themselves.
Our research is improving our understanding of the disease to help scientists develop novel therapies or improve existing treatment options.
Scientists at Queen Mary University of London have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.
A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.
New findings about a fatal form of blood cancer could aid the development of new drugs with significantly less harmful side effects than existing chemotherapy.
Hear from Barts Cancer Institute researchers
This World Cancer Day, hear from the Director of Barts Cancer Institute (BCI), Professor Nick Lemoine, and BCI researchers Dr Ioanna Keklikoglou and Dr Lovorka Stojic, about the work they are doing in the fight against cancer and the importance of international collaboration in cancer research.
- Learn about studying at Queen Mary's Barts and The London School of Medicine and Dentistry
- Learn more about the Barts Cancer Institute
- Find out how to donate for World Cancer Day
For media information, contact:Press Office